EUVIMEDEUVIMED entdecken
Crossref

Survival following resection of 10,244 lung neuroendocrine tumours: a population study

Marie Line El Asmar iD, Mohamed Mortagy, Benjamin E White, John Ramage iD

Endocrine-Related Cancer · 2025

DOI: 10.1530/erc-25-0211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2025. Verfasst von Marie Line El Asmar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK. Hauptthemen laut MEDLINE: Lung Neoplasms, Neuroendocrine Tumors. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surgical resection is the primary treatment for lung neuroendocrine tumours (NET) but the optimal follow-up is unclear. This is a population-based analysis of 3,307 patients from England (NCRAS database; 2012–2021) and 6,937 patients from the United States (SEER database; 2003–2022) who underwent surgical resection for lung NET, which explores factors affecting post-surgical survival and optimal follow-up duration in these patients. Kaplan–Meier (KM) analysis estimated overall survival (OS). Cox proportional hazards models identified factors affecting survival. Patients were matched to national life tables (UK and US) by age, sex, and year of diagnosis to compare actual versus expected KM plots. In NCRAS, OS at 1, 3, 5, and 10 years was 99.6, 95.3, and 91.2% respectively, and in SEER 99.7, 95.5, and 91.8% respectively. In both England and the US, most patients presented with stage 1 disease. Multivariable Cox regression analyses showed that increasing age, advanced stage, socioeconomic deprivation, and atypical carcinoid morphology were associated with worse survival in both countries. In addition, in the US, male sex and pneumonectomy or wedge resection were also associated with worse survival. No overlap was observed between actual and expected KM plots in England, either overall or in subgroups of stage 1, typical morphology, or tumour

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNeuroendocrine TumorsSurvival RateHumansEnglandSEER ProgramUnited StatesKaplan-Meier EstimateProportional Hazards ModelsRetrospective StudiesMaleFemaleAdultMiddle AgedAged

Stichwörter der Autor:innen

follow-up durationlife tableslung neuroendocrine neoplasialung neuroendocrine tumourssurvival analysisthoracic surgery

Autor:innen und Institutionen

  • Department of Gastroenterology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
  • Hampshire Hospitals NHS Foundation Trust, Winchester, UK.
  • St. George University School of Medicine, West Indies, Grenada.
  • King's Health Partners NET centre, Kings College Hospital, London, UK.
  • University of Winchester, Hampshire, UK.

ORCID-Profile: Marie Line El Asmar, John Ramage

Zitieren

APA

El Asmar, M. L., Mortagy, M., White, B. E., & Ramage, J. (2025). Survival following resection of 10,244 lung neuroendocrine tumours: a population study. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0211

Vancouver

El Asmar ML, Mortagy M, White BE, Ramage J. Survival following resection of 10,244 lung neuroendocrine tumours: a population study. Endocrine-Related Cancer. 2025. doi:10.1530/erc-25-0211

BibTeX
@article{ElAsmar2025,
  author = {El Asmar, Marie Line and Mortagy, Mohamed and White, Benjamin E and Ramage, John},
  title = {Survival following resection of 10,244 lung neuroendocrine tumours: a population study},
  journal = {Endocrine-Related Cancer},
  year = {2025},
  doi = {10.1530/erc-25-0211}
}
Kostenlos starten →